Treatments
531 articles
BRCA’s Role in Pancreatic Cancer Investigated
The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.
Go Live Your Life
After his pancreatic cancer diagnosis, Dean Jackson took his treatment of chemotherapy, radiation, and a Whipple procedure step by step.
Testing a Combination for Metastatic Pancreatic Cancer
A clinical trial tests an investigational drug, immunotherapy, and radiation in combination against advanced pancreatic cancer.
Adaptive Pre-Surgery Therapy for Patients with Localized Pancreatic Cancer
Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?
Catching Up With Survivors
How are some of our long-term survivors doing? Roberta Luna, Steven Merlin, Camille Moses, Ed Duncan, and Laurie MacCaskill tell all.
An Expanded Access Trial for Cancer Patients with Specific Mutations
An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.
Safety and Effectiveness of a New Drug for Advanced Pancreatic Cancer
Researchers are testing dose safety and effectiveness of a new drug for pancreatic cancer, in combination with gemcitabine.
A New Drug to Target Cancer Cell Enzymes
Researchers are testing a drug that targets the enzymes that help generate energy for cell division, to disrupt pancreatic cancer cell multiplication.
Immunotherapy for Advanced Pancreatic Cancer and Other Solid Tumors
Researchers are testing the use of tumor-infiltrating lymphocytes, a type of immunotherapy, against advanced pancreatic cancer.
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
Testing the Effectiveness of Immunotherapy Added to a New Drug Combination
Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.
Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint
Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.
Pancreatic Cancer Caught Early by Chance
Sandra Wilke chose her pancreatic cancer treatment of chemotherapy and pancreatectomy with an eye to her quality of life. She joined the tumor registry to learn more and help others.
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
The Body and the Brain
When her husband Ryan was diagnosed with pancreatic cancer at age 36, Brooke Dwars decided it was time to take charge.